BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 07, 2011
 |  BC Week In Review  |  Company News  |  Deals

BioTime, Cell Targeting Inc. deal

BioTime acquired substantially all of Cell Targeting's assets for $250,000 and 261,959 in BioTime common shares, valued at $2.1 million based on BioTime's close of $8.13 on...

Read the full 113 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >